Antimicrobial activity of chicken NK-lysin against Eimeria sporozoites

Avian Diseases

Volumn 52, Issue 2, 2008, Pages 302-305

  Hong, Yeong H ^a   Lillehoj, Hyun S ^a   Siragusa, Gregory R ^b   Bannerman, Douglas D ^a   Lillehoj, Erik P ^c  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b RUSSELL RESEARCH CENTER   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Antimicrobial activity; Eimeria; NK lysin; Sporozoites

Indexed keywords

ANTIINFECTIVE AGENT; ANTIPROTOZOAL AGENT; NK LYSIN; NK-LYSIN; PROTEOLIPID; RECOMBINANT PROTEIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIRD DISEASE; CHICKEN; COCCIDIOSIS; DRUG EFFECT; EIMERIA; ESCHERICHIA COLI; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; PATHOGENICITY; SPOROZOITE; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIPROTOZOAL AGENTS; CHICKENS; COCCIDIOSIS; EIMERIA; ESCHERICHIA COLI; IMMUNITY, NATURAL; POULTRY DISEASES; PROTEOLIPIDS; RECOMBINANT PROTEINS; SPOROZOITES; STAPHYLOCOCCUS AUREUS; TRANSFECTION;

ANIMALIA; BACTERIA (MICROORGANISMS); EIMERIA; EIMERIA ACERVULINA; EIMERIA MAXIMA;

EID: 45849153035     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/8083-072307-ResNote.1     Document Type: Article

References (21)

1. Andersson, M., T. Curstedt, H. Jornvall, and J. Johansson. An amphipathic helical motif common to tumourolytic polypeptide NK-lysin and pulmonary surfactant polypeptide SP-B. FEBS Lett. 362:328-332. 1995.
2. Andersson, M., R. Girard, and P. Cazenave. Interaction of NK lysin, a peptide produced by cytolytic lymphocytes, with endotoxin. Infect. Immun. 67:201-205. 1999.
3. Andersson, M., A. Holmgren, and G. Spyrou. NK-lysin, a disulfide-containing effector peptide of T-lymphocytes, is reduced and inactivated by human thioredoxin reductase. Implication for a protective mechanism against NK-lysin cytotoxicity. J. Biol. Chem. 271:10116-10120. 1996.
4. Andra, J., M. H. Koch, R. Bartels, and K. Brandenburg. Biophysical characterization of endotoxin inactivation by NK-2, an antimicrobial peptide derived from mammalian NK-lysin. Antimicrob. Agents Chemother. 48:1593-1599. 2004.
5. Andra, J., and M. Leippe. Candidacidal activity of shortened synthetic analogs of amoebapores and NK-lysin. Med. Microbiol. Immunol. 188:117-124. 1999.
6. Andreu, D., C. Carreno, C. Linde, H. G. Boman, and M. Andersson. Identification of an anti-mycobacterial domain in NK-lysin and granulysin. Biochem. J. 344(Pt. 3):845-849. 1999.
7. Chai, J. Y., and H. S. Lillehoj. Isolation and functional characterization of chicken intestinal intra-epithelial lymphocytes showing natural killer cell activity against tumour target cells. Immunology 63:111-117. 1988.
8. Dulski, P., and M. Turner. The purification of sporocysts and sporozoites from Eimeria tenella oocysts using Percoll density gradients. Avian Dis. 32:235-239. 1988.
9. Ernst, W. A., S. Thoma-Uszynski, R. Teitelbaum, C. Ko, D. A. Hanson, C. Clayberger, A. M. Krensky, M. Leippe, B. R. Bloom, T. Ganz, and R. L. Modlin. Granulysin, a T cell product, kills bacteria by altering membrane permeability. J. Immunol. 165:7102-7108. 2000.
10. Gansert, J. L., V. Kiessler, M. Engele, F. Wittke, M. Rollinghoff, A. M. Krensky, S. A. Porcelli, R. L. Modlin, and S. Stenger. Human NKT cells express granulysin and exhibit antimycobacterial activity. J. Immunol. 170:3154-3161. 2003.
11. Hong, Y. H., H. S. Lillehoj, R. A. Dalloul, W. Min, K. B. Miska, W. Tuo, S. H. Lee, J. Y. Han, and E. P. Lillehoj. Molecular cloning and characterization of chicken NK-lysin. Vet. Immunol. Immunopathol. 110:339-347. 2006.
12. Hong, Y. H., H. S. Lillehoj, E. P. Lillehoj, and S. H. Lee. Changes in immune-related gene expression and intestinal lymphocyte subpopulations following Eimeria maxima infection of chickens. Vet. Immunol. Immunopathol. 114:259-272. 2006.
13. Jacobs, T., H. Bruhn, I. Gaworski, B. Fleischer, and M. Leippe. NK-lysin and its shortened analog NK-2 exhibit potent activities against Trypanosoma cruzi. Antimicrob. Agents Chemother. 47:607-613. 2003.
14. Lillehoj, H. S., W. Min, and R. A. Dalloul. Recent progress on the cytokine regulation of intestinal immune responses to Eimeria. Poult. Sci. 83:611-623. 2004.
15. Linde, C. M., S. Grundstrom, E. Nordling, E. Refai, P. J. Brennan, and M. Andersson. Conserved structure and function in the granulysin and NK-lysin peptide family. Infect. Immun. 73:6332-6339. 2005.
16. Min, W., H. S. Lillehoj, C. M. Ashwell, C. P. van Tassell, R. A. Dalloul, L. K. Matukumalli, J. Y. Han, and E. P. Lillehoj. EST analysis of Eimeria-stimulated intestinal intraepithelial lymphocytes in chickens. Mol. Biotechnol. 30:143-150. 2005.
17. National Committee for Clinical Laboratory Standards. Methods for determining bacterial activity of antimicrobial agents; approved guideline. Wayne, PA. 1999.
18. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard. In: The National Committee for Clinical Laboratory Standards (NCCLS). Wayne, PA. 2002.
19. Schroder-Borm, H., R. Bakalova, and J. Andra. The NK-lysin derived peptide NK-2 preferentially kills cancer cells with increased surface levels of negatively charged phosphatidylserine. FEBS Lett. 579:6128-6134. 2005.
20. Stenger, S., D. A. Hanson, R. Teitelbaum, P. Dewan, K. R. Niazi, C. J. Froelich, T. Ganz, S. Thoma-Uszynski, A. Melian, C. Bogdan, S. A. Porcelli, B. R. Bloom, A. M. Krensky, and R. L. Modlin. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282:121-125. 1998.
21. Zhang, G., C. R. Ross, and F. Blecha. Porcine antimicrobial peptides: new prospects for ancient molecules of host defense. Vet. Res. 31:277-296. 2000.